Self-Advocacy and Attitude: How Anna Survives (and Thrives) in Her Life with Wegener’s Granulomatosis (Pt. 3)
Photo courtesy of Anna Smith

Self-Advocacy and Attitude: How Anna Survives (and Thrives) in Her Life with Wegener’s Granulomatosis (Pt. 3)

Before you read, make sure you check out Parts 1 and 2 of our interview. In Part 1, we discussed what Wegener's granulomatosis (GPA) is, Anna's diagnostic journey, and her first episode of symptoms.…

Continue Reading Self-Advocacy and Attitude: How Anna Survives (and Thrives) in Her Life with Wegener’s Granulomatosis (Pt. 3)
Raising Stevens-Johnson Syndrome Awareness: Viktoria’s Story (Pt. 2)
Photo by Eyestix Studio on Unsplash: https://unsplash.com/photos/36zZoXDrGmI

Raising Stevens-Johnson Syndrome Awareness: Viktoria’s Story (Pt. 2)

Don't forget to read Part 1 of our interview, where we discuss what Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are, and learn more about how Viktoria ended up hospitalized. Today,…

Continue Reading Raising Stevens-Johnson Syndrome Awareness: Viktoria’s Story (Pt. 2)
GBS from Zika Virus Linked to Poor Olfactory Function
ckstockphoto / Pixabay

GBS from Zika Virus Linked to Poor Olfactory Function

Postnatal Zika virus can cause other complications and health issues for those affected. According to Neurology Advisor, one such complication is Guillain-Barré syndrome (GBS). Researchers believe that GBS following postnatal…

Continue Reading GBS from Zika Virus Linked to Poor Olfactory Function
Self-Advocacy and Attitude: How Anna Survives (and Thrives) in Her Life with Wegener’s Granulomatosis (Pt. 2)
Photo courtesy of Anna Smith

Self-Advocacy and Attitude: How Anna Survives (and Thrives) in Her Life with Wegener’s Granulomatosis (Pt. 2)

Before you read any further, make sure you've read Part 1 of our interview, where Anna and I discussed what Wegener's granulomatosis (GPA) is, her diagnostic journey, and how she managed her…

Continue Reading Self-Advocacy and Attitude: How Anna Survives (and Thrives) in Her Life with Wegener’s Granulomatosis (Pt. 2)
Raising Stevens-Johnson Syndrome Awareness: Viktoria’s Story (Pt. 1)
Photo by Eyestix Studio on Unsplash: https://unsplash.com/photos/36zZoXDrGmI

Raising Stevens-Johnson Syndrome Awareness: Viktoria’s Story (Pt. 1)

Viktoria Cupay is no stranger to raising awareness about underserved and invisible illnesses. In 2016, two years after she began searching for a diagnosis, Viktoria found out that she was…

Continue Reading Raising Stevens-Johnson Syndrome Awareness: Viktoria’s Story (Pt. 1)
The FDA Grants Approval to Begin Dosing First-in-Human CRISPR Technology to Treat Duchenne Muscular Dystrophy
source: pixabay.com

The FDA Grants Approval to Begin Dosing First-in-Human CRISPR Technology to Treat Duchenne Muscular Dystrophy

   Business Wire published an August 10th news release announcing that Cure Rare Disease, a non-profit based in Boston, Massachusetts received FDA approval to administer CRD-TMH-001 (CRD), its first-ever therapeutic.…

Continue Reading The FDA Grants Approval to Begin Dosing First-in-Human CRISPR Technology to Treat Duchenne Muscular Dystrophy
Self-Advocacy and Attitude: How Anna Survives (and Thrives) in Her Life with Granulomatosis (Pt. 1)
Photo courtesy of Anna Smith

Self-Advocacy and Attitude: How Anna Survives (and Thrives) in Her Life with Granulomatosis (Pt. 1)

When Anna tells me about her diagnosis of Wegener’s granulomatosis just about thirty years ago, she shares that she does all that she can to not allow it to encompass…

Continue Reading Self-Advocacy and Attitude: How Anna Survives (and Thrives) in Her Life with Granulomatosis (Pt. 1)

Editor’s Choice: A Childhood Tragedy, New Findings in NAFLD, And the Start of a Clinical Trial

Happy Monday! This week, we have details on a sad story of a toddler passing away from very rare mesenchymal chondrosarcoma, new research about the genetic risk factors of non-alcoholic…

Continue Reading Editor’s Choice: A Childhood Tragedy, New Findings in NAFLD, And the Start of a Clinical Trial
New Treatment Formulation for Ovarian Cancer and Other Rare Cancers Available in Germany
source: unsplash.com

New Treatment Formulation for Ovarian Cancer and Other Rare Cancers Available in Germany

According to a story from Benzinga, the pharmaceutical company Inceptua Group has recently announced that the medicine paclitaxel micellar (marketed as Apealea) is now available in Germany. This medication is…

Continue Reading New Treatment Formulation for Ovarian Cancer and Other Rare Cancers Available in Germany

How Quris is Aiming to Address Fragile X (and Other Rare Diseases) through Bio-AI Drug Development (Pt. 2)

Before reading, don't forget to head to Part 1 to learn more about Quris' founder Isaac Bentwich, why Quris was developed, and how the company is using its innovative bio-AI drug development…

Continue Reading How Quris is Aiming to Address Fragile X (and Other Rare Diseases) through Bio-AI Drug Development (Pt. 2)
Rare Classroom: Galactosemia
source: shutterstock

Rare Classroom: Galactosemia

Welcome to the Rare Classroom, a new series from Patient Worthy. Rare Classroom is designed for the curious reader who wants to get informed on some of the rarest, most…

Continue Reading Rare Classroom: Galactosemia

How Quris is Aiming to Address Fragile X (and Other Rare Diseases) through Bio-AI Drug Development (Pt. 1)

Many people laud the accomplishments of clinical trials – and for, in some cases, good reason. Clinical trials have been crucial in identifying and developing therapeutic options for patients to…

Continue Reading How Quris is Aiming to Address Fragile X (and Other Rare Diseases) through Bio-AI Drug Development (Pt. 1)

How “Voices” Offers a New Avenue of Connection for the Chronic Illness and Rare Disease Communities

It’s no secret that being a part of the chronic illness and/or rare disease community can sometimes be lonely and isolating. Many people, while empathetic to the challenges faced within…

Continue Reading How “Voices” Offers a New Avenue of Connection for the Chronic Illness and Rare Disease Communities